This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_FIBROSARCOMA_EXALLC for full statistics.
Fibrosarcoma
C3_FIBROSARCOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
246 |
4. Check minimum number of eventsNone |
246 |
5. Include endpointsNone |
246 |
6. Filter based on genotype QC (FinnGen only) |
246 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Fibrosarcoma
based on the number of shared cases.
Similar with more cases:
- Fibrosarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 246 | 118 | 128 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 50.83 | 49.98 | 51.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 230
- Matched controls
- 2300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
44.2
41
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
22.2
21
*
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
17.9
17
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
17.9
17
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
17.9
17
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
16.9
16
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
16.9
16
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
15.8
15
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
15.8
15
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
171.2
15.7
16
*
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
14.7
14
*
ZZA00
NOMESCO Finland
Split skin graft
12.0
13.9
25
23
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
13.7
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.7
13
*
130
Kela drug reimbursment
Malignant tumour
5.0
13.2
44
103
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
12.6
12
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
12.6
12
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
12.6
12
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
14.5
12.2
20
15
ZZR10
NOMESCO Finland
Flap of skin and muscle
31.9
11.8
15
5
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
11.6
11
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
11.6
11
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
11.6
11
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.6
11
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
10.4
11.0
21
22
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
13.8
10.8
18
14
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.5
10
*
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.5
10.4
37
93
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
9.4
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.3
9.4
20
26
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
38.3
9.1
11
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
11.4
8.9
16
15
ZZR00
NOMESCO Finland
Flap of skin
7.9
8.6
19
26
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.4
8
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
8.4
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
8.4
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
7.6
26
63
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
7.5
21
41
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
7.4
61
282
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
7.3
7
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
7.3
7
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
7.0
7.3
17
26
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.2
75
394
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
7.4
7.1
16
23
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
17.3
6.8
10
6
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
41.3
6.8
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.7
113
727
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
71.8
6.5
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
71.8
6.5
7
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
7.4
6.3
14
20
C49.45
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of abdominal fibrosarcoma
+∞
6.3
6
*
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
6.3
6
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
6.3
6
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
13.0
6.1
10
8
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
45
173
2.96
8.88
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
110
762
1.80
4.82
2.6
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
45
241
2.06
4.24
1.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
97
2.39
3.31
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
24
3.85
2.70
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
46
2.69
2.39
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
136
1125
1.47
2.29
10.8
9.3
e9/l
3.9
4.2
0.83
123
985
(3044640) Blood type and Crossmatch panel - Blood
86
658
1.47
2.13
2.4
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
25
3.27
2.11
1.8
3.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
111
893
1.44
2.11
5.6
5.9
%
56.7
58.4
0.67
105
839
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
68
499
1.50
2.06
2.3
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
44
294
1.60
2.01
2.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
114
931
1.42
1.96
3.9
4.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
22
3.24
1.89
1.1
1.7
ug/l
12.6
17.3
—
7
22
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
28
2.92
1.88
1.5
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
175
1552
1.44
1.83
9.0
7.8
u/l
81.2
81.1
0.01
169
1432
(3023419) Bacteria identified in Sputum by Culture
8
29
2.82
1.80
1.5
2.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
110
904
1.39
1.78
6.0
6.2
%
27.4
26.6
0.30
104
846
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
54
2.28
1.77
1.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
118
988
1.37
1.68
5.9
5.8
e9/l
1.7
1.9
1.26
104
871
(3026389) Candida sp identified in Specimen by Organism specific culture
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
25
2.85
1.66
1.4
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
115
963
1.36
1.62
5.9
5.8
e9/l
0.6
0.6
0.57
102
833
(3006315) Basophils [#/volume] in Blood
115
966
1.36
1.57
5.9
5.9
e9/l
0.0
0.0
0.06
101
836
(3021788) Differential panel - Synovial fluid
8
33
2.47
1.55
1.4
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
15
3.38
1.53
1.0
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
103
857
1.35
1.48
6.2
9.4
inr
1.0
1.3
9.23
25
238
(3006504) Eosinophils/100 leukocytes in Blood
106
887
1.34
1.46
5.9
6.0
%
3.2
2.7
0.92
100
829
(3003396) Base excess in Arterial blood by calculation
36
248
1.53
1.46
5.3
6.9
mmol/l
0.4
1.4
0.74
28
199
(3013115) Eosinophils [#/volume] in Blood
117
994
1.34
1.45
6.1
6.2
e9/l
0.2
0.2
0.12
102
879
(3019069) Monocytes/100 leukocytes in Blood
106
889
1.34
1.43
6.2
6.3
%
8.9
8.7
0.37
100
837
(42870588) Differential panel, method unspecified - Blood
80
644
1.36
1.41
5.9
5.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
109
923
1.32
1.36
5.9
6.2
mmol/l
1.2
1.2
0.02
102
830
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
125
1082
1.32
1.33
8.2
6.6
umol/l
13.5
11.4
0.42
119
1019
(3022096) Basophils/100 leukocytes in Blood
102
863
1.31
1.26
6.1
5.9
%
0.7
0.6
1.17
96
805
(3019309) Folate [Moles/volume] in Red Blood Cells
30
423
0.67
1.25
1.9
1.8
nmol/l
1099.5
1254.8
0.39
23
331
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
40
2.03
1.13
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
52
1.96
1.07
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
52
1.96
1.07
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
30
216
1.44
1.01
1.6
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
54
1.89
0.98
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
36
1.97
0.98
1.9
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
152
1383
1.26
0.97
3.5
4.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
20
290
0.66
0.97
31.1
24.6
—
1.4
—
0
46
(3021440) Promyelocytes/100 leukocytes in Blood
22
151
1.50
0.94
2.6
4.1
%
0.1
0.2
—
9
45
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
27
2.25
0.94
2.0
3.6
—
—
—
0
0
(3013512) EKG study
73
612
1.27
0.94
3.7
4.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
52
1.76
0.93
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
113
999
1.24
0.92
6.4
7.1
mmol/l
1.2
1.2
0.57
98
850
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
320
0.69
0.91
1.3
1.3
iu/ml
21.3
35.1
—
5
107
(3025159) Blasts/100 leukocytes in Blood
21
144
1.50
0.91
2.7
4.2
%
0.0
0.2
—
8
38
(40761511) CBC panel - Blood by Automated count
209
1989
1.34
0.86
14.5
14.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
71
599
1.26
0.86
3.0
3.2
mg/l
32.5
162.2
0.65
48
389
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
74
860
0.80
0.84
2.9
4.0
ng/l
23.1
45.8
2.71
52
622
(3026008) Bacteria identified in Urine by Culture
53
640
0.78
0.84
2.5
3.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
73
621
1.25
0.82
3.0
3.1
mmol/l
8.0
7.4
0.45
65
517
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
35
446
0.75
0.82
1.4
1.7
pmol/l
497.8
472.9
0.12
28
367
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
32
1.90
0.82
2.8
3.7
e9/l
2.9
4.7
—
6
32
(3004588) Protein electrophoresis panel - Serum or Plasma
9
151
0.58
0.81
5.1
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
157
1450
1.23
0.81
3.6
4.3
mm/h
10.9
13.1
1.54
143
1326
(40760892) CBC W Ordered Manual Differential panel - Blood
52
426
1.28
0.80
4.6
4.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
33
1.84
0.79
3.0
4.3
%
54.2
60.5
—
6
33
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
60
503
1.26
0.77
11.4
7.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
91
1.57
0.77
1.9
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
59
1.72
0.77
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
59
1.72
0.77
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.77
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
136
0.57
0.75
1.8
2.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
38
1.87
0.74
1.0
1.5
nmol/l
0.7
0.8
—
7
31
(4010399)
19
134
1.45
0.74
1.3
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
357
1.28
0.73
2.7
2.8
e6/l
0.7
1.1
0.79
26
204
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
60
1.69
0.73
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
25
2.02
0.73
1.0
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
126
1.46
0.72
2.7
3.0
e9/l
3.5
4.0
0.63
12
100
(3002179) Metamyelocytes/100 leukocytes in Blood
20
145
1.41
0.68
2.8
4.0
%
0.4
0.4
—
7
32
(3021589) Normoblasts [#/volume] in Blood
97
866
1.20
0.68
10.8
9.8
e9/l
0.0
0.0
1.16
85
706
(3020682) Albumin/Creatinine [Ratio] in Urine
74
644
1.21
0.67
3.7
4.0
mg/mmol
5.3
9.2
0.79
52
407
(3023368) Bacteria identified in Blood by Culture
70
606
1.22
0.67
4.1
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
66
568
1.22
0.67
2.6
3.2
e6/l
0.3
0.6
0.81
54
424
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
78
1.57
0.67
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
95
1.50
0.65
1.1
1.3
iu/ml
75.0
121.5
—
5
34
(3014576) Chloride [Moles/volume] in Serum or Plasma
34
271
1.30
0.65
4.4
6.5
mmol/l
105.5
103.4
2.74
34
261
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
173
1822
0.83
0.63
6.3
6.2
mmol/mol
39.7
40.7
1.05
160
1692
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
167
1.35
0.59
2.7
4.0
%
0.6
0.8
—
9
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
106
1.44
0.59
6.7
9.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
624
1.19
0.58
2.5
3.3
e6/l
18.7
160.7
0.76
57
480
(3045414) Leukocytes [Presence] in Urine
11
73
1.53
0.57
1.4
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
348
0.78
0.57
1.6
1.4
g/l
2.5
2.6
0.16
16
217
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
21
161
1.33
0.54
4.0
4.5
mmol/l
1.2
1.2
0.93
21
142
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
30
244
1.26
0.51
2.5
3.0
umol/l
10.9
8.1
0.22
24
215
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
201
1938
1.20
0.49
16.4
16.0
mg/l
23.9
25.1
0.20
160
1565
(36304419) Bacteria [Presence] in Urine
62
547
1.18
0.49
2.6
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
94
1.40
0.47
2.6
4.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
120
0.66
0.47
3.5
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
48
417
1.19
0.45
2.0
2.8
mosm/kgh2o
564.2
552.6
0.15
43
352
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
113
1.35
0.44
1.1
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
129
1211
1.14
0.43
4.1
4.8
mmol/l
6.5
6.8
1.51
123
1140
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
93
0.64
0.43
1.3
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
213
1.25
0.43
3.6
3.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
29
241
1.23
0.42
2.2
2.9
%
1.8
1.8
0.00
23
218
(3004809) Band form neutrophils/100 leukocytes in Blood
5
32
1.57
0.42
1.8
3.5
%
0.6
0.7
—
5
23
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
58
1.39
0.42
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
114
1.34
0.42
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
78
710
1.14
0.41
2.7
3.8
e6/l
116.7
70.7
0.27
59
518
(3011648) Oxygen content in Venous blood
0
15
0.00
0.41
0.0
2.2
—
11.0
—
0
15
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
6.6
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
59
1.37
0.41
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
141
1334
1.13
0.41
3.3
4.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
196
1.25
0.41
2.7
2.1
g/l
0.2
0.2
0.03
24
181
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
187
1.25
0.40
5.7
6.4
mmol/l
1.3
1.3
0.10
23
178
(3000991) Gas panel - Venous blood
22
178
1.26
0.40
6.5
7.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.2
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
235
1.22
0.38
5.0
4.3
ug/l
4.9
28.4
0.68
23
189
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
245
1.21
0.37
1.9
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
37
1.36
0.37
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
19
153
1.26
0.36
4.4
3.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
13
167
0.77
0.35
4.2
3.6
ng/l
100.8
83.6
0.38
13
152
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
73
1.39
0.35
2.3
3.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
14
177
0.78
0.34
2.8
1.9
nmol/l
283.1
395.2
1.59
14
161
(3000492) Spirometry study
20
164
1.24
0.34
1.6
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
68
622
1.13
0.33
4.9
4.4
ph
7.4
7.4
0.38
19
113
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
29
248
1.19
0.33
2.0
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
137
1.26
0.33
2.5
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
175
0.79
0.32
3.9
3.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
222
1.19
0.31
1.4
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
13
102
1.29
0.30
1.1
1.2
u/ml
333.6
148.0
0.58
13
92
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
148
1.23
0.30
1.3
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
55
1.28
0.30
1.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
106
0.75
0.29
3.4
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
107
0.74
0.29
3.6
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
337
1.15
0.29
2.7
2.9
e6/l
1.3
1.8
0.20
19
186
(3008898) HLA-B27 [Presence]
8
62
1.30
0.28
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
113
1.25
0.27
1.2
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
13
104
1.26
0.27
3.6
3.5
pmol/l
4.6
4.8
0.40
13
90
(3052851) Hemolysis interference index of Serum or Plasma
8
66
1.22
0.27
4.1
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
66
1.22
0.27
2.9
5.2
—
—
—
0
0
(4034850)
5
75
0.66
0.26
4.4
10.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
264
1.16
0.26
8.5
8.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
47
429
1.12
0.24
1.9
2.6
e6/l
3.2
5.0
1.54
42
377
(3019060) Gas panel - Arterial blood
18
152
1.20
0.24
3.3
4.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
147
0.81
0.24
1.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
38
343
1.13
0.24
1.8
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
388
0.89
0.23
1.3
1.2
u/ml
0.5
1.1
—
6
119
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
219
1.16
0.23
1.1
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
460
0.90
0.23
3.5
3.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
39
1.29
0.23
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
39
1.29
0.23
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
39
1.29
0.23
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
248
1.15
0.23
5.9
4.9
%
32.6
31.9
0.14
19
156
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
190
1940
0.91
0.22
4.8
5.2
mmol/l
2.8
2.7
0.45
171
1779
(3014051) Protein [Presence] in Urine by Test strip
5
42
1.19
0.21
1.6
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
198
0.85
0.21
1.8
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
8.8
—
0
11
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
26.8
—
0
12
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
12
0.00
0.21
0.0
1.5
—
24.1
—
0
12
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.3
—
225.0
—
0
12
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
0.9
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
50
1.20
0.20
1.2
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.2
1.8
—
—
—
0
0
(3019225) pH of Specimen
22
194
1.15
0.19
3.8
4.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
403
0.90
0.19
2.9
4.0
ng/l
32.8
258.5
1.81
29
324
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
195
1.14
0.18
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
138
1.17
0.18
1.8
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
110
1.19
0.17
2.5
3.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
83
792
1.07
0.17
2.7
2.6
ug/l
190.5
130.2
0.87
75
721
(1002224) Polysomnography panel
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
168
1.14
0.16
3.8
2.9
ml/min/173m2
61.4
61.0
—
8
71
(3009261) Glucose [Presence] in Urine by Test strip
93
967
0.94
0.16
3.5
4.0
estimate
0.0
0.0
0.50
19
164
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
197
1.13
0.16
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
77
0.77
0.16
1.2
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
80
0.74
0.15
3.0
3.4
mmol/l
3.8
4.1
—
6
72
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
955
0.94
0.15
4.3
5.3
estimate
0.0
0.0
0.00
20
168
(3041096) Erythrocytes [Presence] in Urine by Automated
50
530
0.93
0.14
3.4
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
610
0.94
0.14
3.4
4.3
%
22.0
21.6
0.07
31
289
(3021960) Folate [Moles/volume] in Serum or Plasma
48
508
0.93
0.13
1.4
1.5
nmol/l
24.9
20.4
0.74
43
422
(3048689) Calprotectin [Mass/mass] in Stool
18
200
0.89
0.13
2.1
2.2
ug/g
112.0
161.6
0.55
18
157
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
506
0.94
0.12
2.1
2.0
mg/l
3.1
3.0
0.08
41
451
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
187
1896
0.94
0.12
4.5
4.7
mmol/l
4.7
4.6
0.33
170
1753
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
186
1885
0.95
0.11
4.4
4.7
mmol/l
1.4
1.5
1.35
169
1726
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
429
1.06
0.09
1.9
1.7
mg/l
0.9
1.2
0.66
35
332
(3003694) ABO and Rh group [Type] in Blood
49
512
0.95
0.09
1.4
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
47
1.07
0.09
1.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
77
794
0.96
0.09
2.3
2.3
nmol/l
77.2
77.1
0.01
71
691
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
56
1.07
0.08
1.3
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
63
0.79
0.08
7.4
3.8
—
3.8
—
0
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
64
0.78
0.08
7.8
3.8
mg/l
27.5
31.4
—
5
52
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
64
0.78
0.08
7.8
3.8
mg/l
39.9
173.1
—
5
53
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
207
2052
1.06
0.08
12.4
11.0
u/l
27.7
25.8
0.72
198
1976
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
185
1831
1.04
0.07
17.1
14.6
ml/min/173m2
80.2
77.8
0.89
161
1507
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
85
830
1.04
0.07
1.8
2.1
pmol/l
104.4
93.3
1.34
50
416
(3049717) Cytology report of Urine Cyto stain
9
88
1.02
0.07
1.7
3.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
78
761
1.04
0.07
4.6
5.0
ug/l
2.6
2.6
0.00
68
668
(3026361) Erythrocytes [#/volume] in Blood
214
2125
1.05
0.06
24.6
22.9
e12/l
4.5
4.5
0.37
208
2061
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
73
748
0.97
0.06
3.9
4.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
214
2126
1.05
0.06
24.6
22.9
e9/l
7.3
6.8
0.43
208
2063
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
131
0.91
0.05
1.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
63
646
0.97
0.05
3.0
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
53
515
1.04
0.05
4.5
4.4
estimate
0.0
0.0
0.00
20
161
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
181
1825
0.97
0.05
3.9
4.2
mmol/l
1.4
1.3
1.33
165
1668
(3035350) Ketones [Presence] in Urine by Test strip
94
955
0.97
0.04
3.4
3.9
estimate
0.0
0.0
0.00
21
168
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
146
1445
1.03
0.04
3.5
3.9
pmol/l
14.9
15.0
0.11
132
1284
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
28
270
1.04
0.03
1.3
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
75
738
1.02
0.03
2.9
3.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
169
1702
0.98
0.03
18.1
16.8
%
40.4
39.4
0.84
114
1188
(3020891) Body temperature
10
92
1.09
0.03
3.1
3.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
187
1881
0.98
0.03
4.6
4.9
mmol/l
6.0
6.1
0.67
170
1713
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1089
1.02
0.02
2.5
2.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
63
639
0.98
0.02
2.4
2.6
u/l
55.4
54.9
0.03
58
585
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
106
0.94
0.01
2.4
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
224
1.03
0.00
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
254
1.03
0.00
1.9
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
213
2124
1.02
0.00
24.7
22.9
e9/l
245.9
245.0
0.07
207
2067
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
674
1.01
0.00
5.7
3.5
mmol/l
2.4
2.4
0.18
59
581
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
301
1.00
0.00
1.3
1.3
u/ml
1.1
4.5
1.70
11
116
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
174
1744
0.99
0.00
4.3
4.7
mu/l
1.9
1.9
0.24
159
1566
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
127
1266
1.01
0.00
3.1
3.3
u/l
44.6
51.9
0.73
120
1170
(40768797) Stomach Pathology biopsy report
27
267
1.01
0.00
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
12
117
1.03
0.00
1.2
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
51
507
1.01
0.00
1.6
1.6
mmol/l
1.4
1.3
0.23
44
419
(3012544) pH of Venous blood
20
204
0.98
0.00
2.5
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
442
0.99
0.00
2.6
3.0
ug/l
0.6
0.8
1.48
31
286
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
67
0.89
0.00
1.8
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
71
0.99
0.00
1.3
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
49
1.02
0.00
1.0
1.2
—
20.0
—
0
5
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
14.0
—
725.5
—
0
6
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
25.0
—
0
5
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.4
—
1.6
—
0
8
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
4.8
—
0
6
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
120
1.00
0.00
1.4
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
40.8
—
0
5
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.9
—
0.7
—
0
7
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
54
0.92
0.00
2.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
63
0.95
0.00
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
15.5
—
1500.7
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FIBROSARCOMA – Fibrosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).